期刊文献+

有效的高效抗反转录病毒治疗后低CD4/CD8比值HIV/AIDS患者免疫学特征分析 被引量:10

Immunological characteristics of HIV/AIDS patients with low CD4/CD8 ratio after receiving highly active antiretroviral therapy effectively
下载PDF
导出
摘要 目的对比研究有效的高效抗反转录病毒治疗(highly active antiretroviral therapy,HAART)后低CD4/CD8比值组与高CD4/CD8比值组患者相关免疫学特征。方法选择接受HAART≥96周、CD4^+T淋巴细胞≥500/μl、HIV载量低于检测值下限的HIV感染者/AIDS患者(HIV/AIDS患者)109例,从中选出CD4/CD8比值≥0.82的患者28例及CD4/CD8比值≤0.48的患者28例,对比分析2组T淋巴细胞上CD38、人类白细胞抗原DR(HLA-DR)、CD27、CD28、CD45RA及CD31的表达,进而分析2组外周血T淋巴细胞的免疫活化与免疫老化状况。结果①低CD4/CD8比值组的基线CD4^+T淋巴细胞计数和基线CD4/CD8比值较高CD4/CD8比值组低(P<0.05);②低CD4/CD8比值组HLA-DR^+CD8^+T淋巴细胞频率、处于中期分化阶段(CD27^-CD28^+)的CD4^+T淋巴细胞频率及处于晚期分化阶段(CD27^-CD28^-)的CD4^+和CD8^+T淋巴细胞频率高于高CD4/CD8比值组(P均<0.05),而处于早期分化阶段(CD27^+CD28^+)的CD4^+和CD8^+T淋巴细胞频率低于高CD4/CD8比值组(P均<0.05);③低CD4/CD8比值组纯真CD4^+和与CD8^+T淋巴细胞频率以及CD31^+纯真CD8^+T淋巴细胞的频率低于高CD4/CD8比值组(P均<0.05)。结论①低基线CD4^+T淋巴细胞计数和低基线CD4/CD8比值HIV/AIDS患者有效HAART后CD4/CD8比值仍然相对较低,应及早起始HAART,预防CD4/CD8低比值持续的发生;②有效HAART后低CD4/CD8比值的HIV/AIDS患者表现出更为严重的免疫活化和免疫老化现象,针对这些免疫紊乱应给予除HAART外新的干预措施。 Objective To compare immunological characteristics between HIV/AIDS patients with low CD4/CD8 ratio after receiving highly active antiretroviral therapy(HAART) effectively and those with high CD4/CD8 ratio.Methods Among 109 HIV/AIDS patients with CD4^+ T lymphocyte count ≥500 /μl and undetectable viral load after more than 96 weeks of HAART,28 patients with CD4/CD8 ratio ≥0.82 were selected as high CD4/CD8 ratio group,and 28 with CD4/CD8 ratio ≤0.48 as low CD4/CD8 ratio group.The expressions of CD38,HLA-DR,CD27,CD28,CD45 RA and CD31 on T lymphocytes of peripheral blood were compared between the two groups,and the immune activation and immunosenescence of the two groups were analyzed.Results Low CD4/CD8 ratio group showed significantly lower baseline CD4^+ T lymphocyte count and baseline CD4/CD8 ratio than high CD4/CD8 ratio group(P0.05).Low CD4/CD8 ratio group showed significantly higher frequency of HLA-DR^+ cells of CD8^+ T lymphocytes,higher frequency of CD4^+ T lymphocytes in intermediate stage(CD27-CD28^+),higher frequency of CD4^+ or CD8^+ T lymphocytes in late differentiation stage(CD27^-CD28^-)(P0.05),and lower frequency of CD4^+ or CD8^+ T lymphocytes in early differentiation stage(CD27^+CD28^+) than high CD4/CD8 ratio group(P0.05).Besides,low CD4/CD8 ratio group had significandy lower frequency of naive CD4^+ and CD8^+ T lymphocytes and lower frequency of CD31^+ naive CD8^+ T lymphocytes than high CD4/CD8 ratio group(P0.05).Conclusions HIV/AIDS patients with low baseline CD4^+ T lymphocyte count and low baseline CD4/CD8 ratio are inclined to have relatively low CD4/CD8 ratio after receiving effective HAART,thus an early initiation of HAART is necessary to prevent the occurrence of consistendy low CD4/CD8 ratio.HIV/AIDS patients with low CD4/CD8 ratio after effective HAART show more serious T lymphocyte immune activation and immunosenescence,so in addition to HAART,novel interventions should be given for ongoing immune dysfunction in such patients.
出处 《传染病信息》 2015年第6期357-361,共5页 Infectious Disease Information
基金 2014年首都卫生发展科研专项项目(2014-2-2173) 国家自然科学基金(81371804)
关键词 获得性免疫缺陷综合征 HIV 淋巴细胞计数 T-淋巴细胞亚群 acquired immunodeficiency syndrome HIV lymphocyte count T-lymphocyte subsets
  • 相关文献

参考文献19

  • 1史继静,张昕,徐若男,王福生.细胞治疗与AIDS功能性治愈[J].传染病信息,2015,28(6):344-347. 被引量:4
  • 2Margolick JB, Gange SJ, Detels R, et al. Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infection[J]. J Acquit Immune Defic Syndr, 2006, 42(5):620-626.
  • 3Serrano-Villar S, Gutierrez C, Vallejo A, et al. The CD4/CD8 ratio in HIV-infeeted subjects is independently associated with T-cell activation despite long-term viral suppression[J]. J Infect, 2013, 66(1):57-66.
  • 4Sainz T, Serrano-Villar S, Diaz L, et al. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults[J]. AIDS, 2013, 27(9):1513-1516.
  • 5Serrano-Villar S, Moreno S, Fuentes-Ferrer M, et al. The CD4: CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infeeted patients with immunological recovery[J]. HIV Med, 2014, 15(1):40-49.
  • 6Serrano-Villar S, Perez-Elias MJ, Dronda F, et al. Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio [J]. PLoS One, 2014, 9(1):e85798.
  • 7Menozzi M, Zona S, Santoro A, et al. CD4/CD8 ratio is not predictive of multi-morbidity prevalence in HIV-infected patients but identify patients with higher CVD risk[J]. J Int AIDS Soc, 2014, 17(4 Suppl 3):s19709.
  • 8Bemal E, Serrano J, Perez A, et al. The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment[J]. J Int AIDS Soc, 2014, 17(4 Suppl 3):S19723.
  • 9Torti C, Prosperi M, Motta D, et al. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy[J]. Clin Microbiol Infect, 2012, 18(5):449-458.
  • 10Leung V, Gillis J, Raboud J, et al. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy[J]. PLoS One, 2013, 8(10):e77665.

二级参考文献31

  • 1Petz LD, Burnett JC, Li H, et al. Progress toward curing HIV infection with hematopoietic cell transplantation[J]. Stem Cells Cloning, 2015, 8:109-116.
  • 2Hutter G, Nowak D, Mossner M, et al. Long-term control of HIV by CCR5 Deha32/Delta32 stem-cell transplantation[J]. N Engl J Med, 2009, 360(7):692-698.
  • 3Allers K, Htitter G, Hofmann J, et al. Evidence for the cure of HIV infection by CCR5A32/A32 stem cell transplantation [J]. Blood, 2011, 117(10):2791-2799.
  • 4Ruelas DS, Greene WC. An integrated overview of HIV-1 latency [J]. Cell, 2013, 155(3):519-529.
  • 5Lafeuillade A. Eliminating the HIV reservoir[J]. Curr HIV/AIDS Rep, 2012, 9(2):121-131.
  • 6Chomont N, El-Far M, Ancuta P, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation[J]. Nat Med, 2009, 15(8):893-900.
  • 7Perreau M, Savoye AL, De Crignis E, et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production[J]. J Exp Med, 2013, 210(1): 143-156.
  • 8Massanella M, Martinez-Picado J, Blanco J. Attacking the HIV reservoir from the immune and viral perspective [J]. Curr HIV/ AIDS Rep, 2013, 10(1):33-41.
  • 9Fukazawa Y, Lum R, Okoye AA, et al. B cell follicle sanctuary permits persistent productive simian immunodeficieney virus infection in elite controllers[J]. Nat Med, 2015, 21(2):132-139.
  • 10Lusic M, Giacca M. Regulation of HIV-1 latency by chromatin structure and nuclear architecture [J]. J Mol Biol, 2015, 427(3): 688-694.

共引文献3

同被引文献64

引证文献10

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部